Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy

被引:0
作者
Jong Gwang Kim
Baek-Yeol Ryoo
Yeon Hee Park
Bong-Seog Kim
Tae-You Kim
Young-Hyuck Im
Yoon-Koo Kang
机构
[1] Korea Cancer Center Hospital,Department of Hematology
[2] Kyungpook National University School of Medicine,Oncology
[3] Sungkyunkwan University School of Medicine,Department of Oncology/Hematology, Kyungpook National University Hospital
[4] Seoul Veterans Hospital,Division of Hematology
[5] Seoul National University Hospital,Oncology, Department of Medicine, Samsung Medical Center
[6] Seoul National University College of Medicine,Department of Internal Medicine, Division of Haematology and Oncology
[7] University of Ulsan College of Medicine,Department of Internal Medicine, Cancer Research Institute
[8] Asan Medical Center,Division of Oncology, Department of Internal Medicine
来源
Cancer Chemotherapy and Pharmacology | 2008年 / 61卷
关键词
Gastric cancer; Prognostic factor; Cisplatin; Chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:301 / 307
页数:6
相关论文
共 203 条
[1]  
Pisani P(1999)Estimates of the worldwide mortality from 25 cancers in 1990 Int J Cancer 83 18-29
[2]  
Parkin DM(1993)Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer Cancer 72 37-41
[3]  
Bray F(1995)Randomized comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer Br J Cancer 71 587-591
[4]  
Ferlay J(1994)Initial or delayed chemotherapy with best supportive in advanced gastric cancer Ann Oncol 5 189-190
[5]  
Murad AM(1993)A phase III randomized study of 5-fluorouracil and cisplatin versus 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil alone in the treatment of advanced gastric cancer Cancer 71 3813-3818
[6]  
Santiago FF(2002)Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer Ann Oncol 13 1893-1898
[7]  
Petroianu A(2000)Docetaxel (Taxotere)-cisplatin (TC): An effective drug combination in gastric carcinoma Ann of Oncol 11 301-306
[8]  
Rocha PR(1999)Phase II study of a combination of irinotecan and cisplatin against metastatic gastric cancer J Clin Oncol 17 319-323
[9]  
Rodrigues MA(2001)Prognostic factors in patients with advanced gastric cancer treated with by noncurative resection: a multivariate analysis Hepatogastroenterology 48 1504-1508
[10]  
Rausch M(2000)The roles of chemotherapy and surgery in gastric carcinoma and the influence of prognostic factors on survival Am J Clin Oncol 23 53-57